Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02042495
Title Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jewish General Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Jewish General Hospital Montreal Quebec H3T1E2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field